SHANNON LACOVIC: Open Payments
NPI 1780121145 · LENOX, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 32 payments from 14 companies in 2025. Trend: 2023 $761 · 2024 $485 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 2 | $156 |
| Otsuka America Pharmaceutical, Inc. | 5 | $126 |
| Exact Sciences Corporation | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| PFIZER INC. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Novo Nordisk Inc | 3 | $50 |
| MERZ NORTH AMERICA, INC. | 1 | $48 |
| ABBVIE INC. | 1 | $29 |
Products named: DAXXIFY, REXULTI, The Cologuard Plus Collection Kit, Auvelity, NURTEC ODT, XIFAXAN, Xeomin, FARXIGA.
Industry payments across MI — which companies pay providers there.
